bn:01711895n
Noun Concept
SYL
No term available
EN
Aclidinium bromide is a long-acting, inhaled muscarinic antagonist approved in the United States on July 24, 2012 as a maintenance treatment for chronic obstructive pulmonary disease. Wikipedia
Relations
Sources